DiPalma Stephen J.

See Remarks at SmartPros Ltd. · on record since Nov 8, 2019
CFO, EVP, Secretary at SELLAS Life Sciences Group, Inc. · on record since Jan 20, 2009
Interim CFO at Inozyme Pharma, Inc. · on record since May 18, 2021
Interim CFO at INTERLEUKIN GENETICS INC · on record since Dec 30, 2014
Interim CFO at Scorpius Holdings, Inc. · on record since Mar 12, 2015
See Remarks at Generation Bio Co. · on record since Jun 11, 2020
Chief Financial Officer at Chemomab Therapeutics Ltd. · on record since May 7, 2020
Interim CFO at Solid Biosciences Inc. · on record since Feb 1, 2021

Insider trading activity of DiPalma Stephen J.

Figures computed from official regulatory filings — .

Insufficient history for a statistical track record (fewer than 5 open-market buys).

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Inozyme Pharma, Inc.Listing unverified	May 18, 2021	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
INTERLEUKIN GENETICS INCListing unverified	Aug 1, 2016	BuyD (derivative)	100,603	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	ClusterFirst in 12mo	SEC
INTERLEUKIN GENETICS INCListing unverified	Aug 1, 2016	Buy	100,603	0.10 USD	$10.1K	conv 83ClusterFirst in 12mo	SEC
INTERLEUKIN GENETICS INCListing unverified	Dec 30, 2014	Buy	249,252	0.10 USD	$24.9K	conv 100ClusterFirst in 12mo	SEC
INTERLEUKIN GENETICS INCListing unverified	Dec 30, 2014	BuyD (derivative)	249,252	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	ClusterFirst in 12mo	SEC
SELLAS Life Sciences Group, Inc.Listing on record	Jan 20, 2009	AwardD (derivative)	47,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SELLAS Life Sciences Group, Inc.Listing on record	Jan 20, 2009	AwardD (derivative)	36,218	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SELLAS Life Sciences Group, Inc.Listing on record	Apr 22, 2008	AwardD (derivative)	19,428	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Inozyme Pharma, Inc.Listing unverified	May 18, 2021	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
INTERLEUKIN GENETICS INCListing unverified	Aug 1, 2016	BuyD (derivative)	100,603	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	ClusterFirst in 12mo	SEC
INTERLEUKIN GENETICS INCListing unverified	Aug 1, 2016	Buy	100,603	0.10 USD	$10.1K	conv 83ClusterFirst in 12mo	SEC
INTERLEUKIN GENETICS INCListing unverified	Dec 30, 2014	Buy	249,252	0.10 USD	$24.9K	conv 100ClusterFirst in 12mo	SEC
INTERLEUKIN GENETICS INCListing unverified	Dec 30, 2014	BuyD (derivative)	249,252	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	ClusterFirst in 12mo	SEC
SELLAS Life Sciences Group, Inc.Listing on record	Jan 20, 2009	AwardD (derivative)	47,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SELLAS Life Sciences Group, Inc.Listing on record	Jan 20, 2009	AwardD (derivative)	36,218	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SELLAS Life Sciences Group, Inc.Listing on record	Apr 22, 2008	AwardD (derivative)	19,428	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC